Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hum Mutat. 2010 Apr;31(4):494-9. doi: 10.1002/humu.21221.
Massively parallel sequencing has tremendous diagnostic potential but requires enriched templates for sequencing. Here we report the validation of an array-based sequence capture method in genetically heterogeneous disorders. The model disorder selected was AR ataxia, using five subjects with known mutations and two unaffected controls. The genomic sequences of seven disease genes, together with two control loci were targeted on a 2-Mb sequence-capture array. After enrichment, the patients' DNA samples were analyzed using one-quarter Roche GS FLX Titanium sequencing run, resulting in an average of 65 Mb of sequence data per patient. This was sufficient for an average 25-fold coverage/base in all targeted regions. Enrichment showed high specificity; on average, 80% of uniquely mapped reads were on target. Importantly, this approach enabled automated detection of deletions and hetero- and homozygous point mutations for 6/7 mutant alleles, and greater than 99% accuracy for known SNP variants. Our results also clearly show reduced coverage for sequences in repeat-rich regions, which significantly impacts the reliable detection of genomic variants. Based on these findings we recommend a minimal coverage of 15-fold for diagnostic implementation of this technology. We conclude that massive parallel sequencing of enriched samples enables personalized diagnosis of heterogeneous genetic disorders and qualifies for rapid diagnostic implementation.
大规模平行测序具有巨大的诊断潜力,但需要进行测序的富集模板。在这里,我们报告了一种基于阵列的序列捕获方法在遗传异质性疾病中的验证。选择的模型疾病是 AR 共济失调,使用了五个已知突变的患者和两个未受影响的对照。七个疾病基因的基因组序列,加上两个对照基因座,被靶向在一个 2-Mb 的序列捕获阵列上。富集后,使用罗氏 GS FLX Titanium 测序仪的四分之一进行患者 DNA 样本分析,每个患者平均获得 65Mb 的序列数据。这足以在所有靶向区域平均达到 25 倍覆盖率/碱基。富集显示出高度的特异性;平均而言,80%的唯一映射读数都在目标上。重要的是,这种方法能够自动检测 6/7 个突变等位基因的缺失、杂合和纯合点突变,并且对已知 SNP 变体的准确率大于 99%。我们的结果还清楚地显示了重复丰富区域序列的覆盖减少,这对可靠检测基因组变体有重大影响。基于这些发现,我们建议将该技术的诊断实施最小覆盖率设定为 15 倍。我们得出结论,富集样本的大规模平行测序能够实现异质性遗传疾病的个体化诊断,并具备快速诊断实施的资格。